A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

Mohamed Hassanein,1 Khalifa Abdallah,2 Anja Schweizer31Betsi Cadwaladr University Health Board, Wales, United Kingdom; 2Clinical Research Center, Alexandria University Hospital, Alexandria, Egypt; 3Global Medical Affairs, Novartis Pharma AG, Basel, SwitzerlandBackground: Several observational studi...

Full description

Bibliographic Details
Main Authors: Hassanein M, Abdallah K, Schweizer A
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/a-double-blind-randomized-trial-including-frequent-patientndashphysici-a17032